中文名称 |
英文名称 |
CAS号 |
化学式 |
结构式图片 |
H-7二盐酸盐 |
hydron;5-(2-methylpiperazin-1-yl)sulfonylisoquinoline;dichloride |
—— |
C14H19Cl2N3O2S |
|
H-3-ALA(3-苯并噻吩)-OH |
(S)-2-amino-3-<1>benzothiophene-3-ylpropionic acid |
72120-71-9 |
C11H11NO2S |
|
H-(2-羟乙基)2-氰基-4-硝基苯胺 |
2-(2-hydroxy-ethylamino)-5-nitro-benzonitrile |
63989-40-2 |
C9H9N3O3 |
|
G蛋白拮抗剂肽 |
G Protein Antagonist |
143675-79-0 |
C57H64N12O9S |
|
G毒毛旋花苷 |
ouabain |
630-60-4 |
C29H44O12 |
|
Gsk肽 |
Gsk peptide |
99278-03-2 |
C47H86N16O13 |
|
Gsh-前列腺素A1 |
Gsh-prostaglandin A1 |
61631-70-7 |
C30H49N3O10S |
|
Gona-1,5,7,9,11,13-hexaen-17-one,3,4-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-,(3a,4b)-(?脿)- |
3,4,15,16-tetrahydro-trans-3,4-bis<(tert-butyldimethylsilyl)oxy>cyclopenta<a>phenanthren-17-one |
143216-83-5 |
C29H42O3Si2 |
|
Gona-1,3,5,7,9-pentaene-11,17-dione,(13a)-(?脿)-(9CI) |
11,17-Dioxo-14β-gonapentaen-1,3,5(10),6,8 |
23462-83-1 |
C17H14O2 |
|
Gona-1,3,5,7,9-pentaen-11-one,17-hydroxy-,(14b,17a)-(?脿)-(9CI) |
14beta-Gona-1,3,5,7,9-pentaen-11-one, 17alpha-hydroxy-, (+-)- |
23462-86-4 |
C17H16O2 |
|
Gona-1,3,5(10),8,14-pentaen-17-one,13-ethyl-3-methoxy-,(?脿)-(8CI,9CI) |
(+/-)-13-ethyl-3-methoxygona-1,3,5(10),8,14-pentaen-17-one |
848-07-7 |
C20H22O2 |
|
Gm1-低聚糖 |
G(M1)-Oligosaccharide |
85373-04-2 |
C37H62N2O29 |
|
Gly-His 盐酸盐 水合物 |
2-[(2-aminoacetyl)amino]-3-(1H-imidazol-5-yl)propanoic acid;hydrochloride |
3486-76-8 |
C8H13ClN4O3 |
|
Givinostat盐酸盐 |
diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphthalen-2-yl-methyl]-ammonium chloride |
199657-29-9 |
C24H27N3O4*ClH |
|
Girards试剂D |
N,N-Dimethylglycine Hydrazide Dihydrochloride |
5787-71-3 |
C4H13Cl2N3O |
|
GinsenoyneK;(3R,10S,8E)-10-氢过氧-1,8-十七碳二烯-4,6-二炔-3-醇 |
(3R,8E,10S)-10-Hydroperoxyheptadeca-1,8-dien-4,6-diyn-3-OL |
141947-42-4 |
C17H24O3 |
|
Gg4去唾液酸-低聚糖 |
Gangliotetraose |
75645-24-8 |
C26H45NO21 |
|
Garg5-溴-3,4-吡啶炔前体 |
5-bromo-4-(trimethylsilyl)pyridin-3-yl triflate |
1413439-82-3 |
C9H11BrF3NO3SSi |
|
Gardenine;[2aS-(2aalpha,4aalpha,7aalpha,7balpha)]-2,2a,4a,7,7a,7b-六氢-2a-羟基-1-氧杂-7-氮杂环戊并[cd]茚-5-羧酸甲酯 |
Gardenine |
139682-36-3 |
C11H13NO4 |
|
GarcinoneC;1,3,6,7-四羟基-8-(3-羟基-3-甲基丁基)-2-(3-甲基-2-丁烯-1-基)-9H-呫吨-9-酮 |
garcinone C |
76996-27-5 |
C23H26O7 |
|
Gamma-蜡烷 |
gammacerane |
559-65-9 |
C30H52 |
|
Gamma-L-谷氨酰-Beta-萘酰胺 |
(S)-2-Amino-5-(naphthalen-2-ylamino)-5-oxopentanoic acid |
14525-44-1 |
C15H16N2O3 |
|
Gamma,2-二氨基苯丙醇 |
3-Amino-3-(2-aminophenyl)propan-1-ol |
886364-15-4 |
C9H14N2O |
|
Galili抗原五糖 |
Lacto-N-difucohexose II |
62258-12-2 |
C38H65NO29 |
|
GZD824甲磺酸盐 |
GZD824 Dimesylate |
1421783-64-3 |
C31H35F3N6O7S2 |
|
GYKI52466,盐酸盐 |
GYKI 52466 hydrochloride |
192065-56-8 |
C17H16ClN3O2 |
|
GYKI-53655水合物 |
5-(4-aminophenyl)-N,8-dimethyl-8,9-dihydro-[1,3]dioxolo[4,5-h][2,3]benzodiazepine-7-carboxamide;hydron;chloride |
143692-48-2 |
C19H21ClN4O3 |
|
GW627368X抑制剂 |
N-(benzenesulfonyl)-2-[4-(4,9-diethoxy-3-oxo-1H-benzo[f]isoindol-2-yl)phenyl]acetamide |
439288-66-1 |
C30H28N2O6S |
|
GW501516甲酯 |
methyl [2-methyl-4-[[[4-methyl-2-[4-(trifluoromethyl)phenyl]thiazol-5-yl]methyl]sulfanyl]peroxy]acetate |
317318-69-7 |
C22H20F3NO3S2 |
|
GW405833盐酸盐 |
(2,3-dichlorophenyl)(5-methoxy-2-methyl-3-(2-morpholinoethyl)-1H-indol-1-yl)methanone |
180002-83-9 |
C23H24Cl2N2O3 |
|
GTx-134; 2-[4-[[(2R)-3-(2,4-二甲基苯氧基)-2-羟基丙基]氨基]-1,2-二氢-2-氧代-3-吡啶基]-6,7-二氢-6-[1-[2-(甲磺酰基)乙基]-4-哌啶基]吡咯并[3,4-f]苯并咪唑-5(3H)-酮 |
2-{4-[(R)-3-(2,4-dimethylphenoxy)-2-hydroxypropylamino]-2-oxo-1,2-dihydropyridin-3-yl}-6-[1-(2-methanesulfonylethyl)piperidin-4-yl]-6,7-dihydro-3H-1,3,6-triaza-s-indacen-5-one |
1008448-19-8 |
C33H40N6O6S |
|
GSKPERK抑制剂 |
1-[5-(4-Amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2,3-dihydro-1H-indol-1-yl]-2-[3-fluoro-5-(trifluoromethyl)phenyl]ethanone |
1337531-89-1 |
C24H19F4N5O |
|
GSK789472盐酸盐 |
1-Phenyl-3-(piperidin-2-ylmethyl)imidazolidin-2-one hydrochloride |
1257326-24-1 |
C15H22ClN3O |
|
GSK2636771甲酯 |
methyl 2-methyl-1-{[2-methyl-3-(trifluoromethyl)phenyl]methyl}-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylate |
1372540-24-3 |
C23H24F3N3O3 |
|
GSK256066三氟乙酸盐 |
GSK256066 2,2,2-trifluoroacetic acid |
1415560-64-3 |
C29H27F3N4O7S |
|
GSK2334470游离态 |
GKS2334470 |
1227911-45-6 |
C25H34N8O |
|
GSK2193874游离态 |
GSK2193874 |
1336960-13-4 |
C37H38BrF3N4O |
|
GSK-3抑制剂(LY2090314) |
7-(2,5-dihydro-4-imidazo[1,2-a]pyridine-3-yl-2,5-dioxo-1H-pyrrol-3-yl)-9-fluoro-1,2,3,4-tetrahydro-2-(1-piperidinyl-carbonyl)-pyrrolo[3,2,1-jk][1,4]benzodiazepine |
603288-22-8 |
C28H25FN6O3 |
|
GSK-3beta 抑制剂 XI |
GSK-3b Inhibitor XI |
626604-39-5 |
C18H15N5O3 |
|
GSK-2110183C无结构图 |
afuresertib |
1047644-62-1 |
C18H17Cl2FN4OS |
|
GSK 525762A; (4S)-6-(4-氯苯基)-N-乙基-8-甲氧基-1-甲基-4H-[1,2,4]三唑并[4,3-a][1,4]苯并二氮杂卓-4-乙酰胺 |
I-BET762 |
1260907-17-2 |
C22H22ClN5O2 |
|
GSK 189254; 6-[(3-环丁基-2,3,4,5-四氢-1H-3-苯并氮杂卓-7-基)氧基]-N-甲基-3-吡啶甲酰胺盐酸盐 |
[3H]-GSK189254 |
945493-87-8 |
C21H25N3O2*ClH |
|
GSK 1292263 盐酸盐 |
5-[({1-[3-(1-Methylethyl)-1,2,4-oxadiazol-5-yl]-4-piperidinyl}methyl)oxy]-2-[4-(methylsulfonyl)phenyl]pyridine hydrochloride |
1032824-54-6 |
C23H28N4O4S*ClH |
|
GSK 1059615; (5Z)-5-[[4-(4-吡啶基)-6-喹啉基]亚甲基]-2,4-噻唑烷二酮 |
GSK1059615 |
958852-01-2 |
C18H11N3O2S |
|
GRANULAR BLUE 粒蓝相似物 |
2-<4-(4-Amidinophenoxy)phenyl>indol-6-carboxamidin-dihydrochlorid |
55453-00-4 |
C22H19N5O*2ClH |
|
GR 127935盐酸盐 |
N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-carboxamide |
148672-13-3 |
C29H31N5O3 |
|
GPR84拮抗剂8 |
2-([1,4]dioxan-2-ylmethoxy)-9-(pyridin-2-ylmethoxy)-6,7-dihydro-pyrimido[6,1-a]isoquinolin-4-one |
1445846-30-9 |
C23H23N3O5 |
|
GPR109A受体激动剂(MK-0354) |
MK-0354 |
851776-28-8 |
C7H8N6 |
|
GNF179代谢物 |
2-(4-Fluorophenyl)-8,8-dimethyl-5,6,7,8-tetrahydroimidazo[1,2-A]pyrazine |
1310455-86-7 |
C14H16FN3 |
|
GNE-495游离态 |
8-amino-N-(1-(cyclopropanecarbonyl)azetidin-3-yl)-2-(3-fluorophenyl)-1,7-naphthyridine-5-carboxamide |
1449277-10-4 |
C22H20FN5O2 |
|